BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 454972)

  • 1. Characterization of calf brain dopamine receptors [proceedings].
    Leavens WJ; Riddall DR
    Br J Pharmacol; 1979 May; 66(1):88P-89P. PubMed ID: 454972
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings].
    Cross AJ; Crow TJ; Owen F
    Br J Pharmacol; 1979 May; 66(1):87P. PubMed ID: 454971
    [No Abstract]   [Full Text] [Related]  

  • 3. Sexual dimorphism in the number of dopamine receptors in limbic and non-limbic areas of rat brain [proceedings].
    Karakiulakis G; Knight A; Powell R; Thomas PJ
    J Endocrinol; 1978 Nov; 79(2):32P-33P. PubMed ID: 731158
    [No Abstract]   [Full Text] [Related]  

  • 4. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
    Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity dopamine receptors (D3) in rat brain.
    Titeler M; List S; Seeman P
    Commun Psychopharmacol; 1979; 3(6):411-20. PubMed ID: 546589
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of surgical ovariectomy on dopamine receptors of the heart and brain].
    Kharchilava OM; Valeeva LA
    Patol Fiziol Eksp Ter; 2008; (4):21-3. PubMed ID: 19202617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain dopamine receptors.
    Seeman P
    Pharmacol Rev; 1980 Sep; 32(3):229-313. PubMed ID: 6117090
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for increased dopamine receptor sensitivity in post mortem brains from patients with schizophrenia [proceedings].
    Cross AJ; Crow TJ; Longden A; Owen F; Poulter M; Riley GJ
    J Physiol; 1978 Jul; 280():37P. PubMed ID: 690887
    [No Abstract]   [Full Text] [Related]  

  • 9. The binding characteristics of 3H-terguride in various brain areas.
    Dobrovský K; Valchár M; Dlabac A
    Act Nerv Super (Praha); 1989 Dec; 31(4):274-5. PubMed ID: 2534687
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain dopamine receptors--research perspectives and potential sites of regulation.
    Dziedzicka-Wasylewska M
    Pol J Pharmacol; 2004; 56(6):659-71. PubMed ID: 15662079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors acting through adenylate cyclase in the CNS.
    Wollemann M
    Acta Physiol Acad Sci Hung; 1980; 55(4):299-304. PubMed ID: 6258390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurobiological aspects of alcoholism].
    Anokhina IP
    Vestn Akad Med Nauk SSSR; 1988; (3):21-7. PubMed ID: 3388967
    [No Abstract]   [Full Text] [Related]  

  • 13. [The distribution of dopamine D1 and D2 receptors in the brain of rodents and carnivores].
    Avgustinovich DF; Nikulina EM
    Zh Evol Biokhim Fiziol; 1992; 28(1):3-8. PubMed ID: 1387995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrastriatal dopamine D2 receptors: distribution, pharmacological characterization and region-specific regulation by clozapine.
    Janowsky A; Neve KA; Kinzie JM; Taylor B; de Paulis T; Belknap JK
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1282-90. PubMed ID: 1534844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of (+/-)12-chloroscoulerine on brain dopamine receptors].
    Chen LJ; Xi Y; Pang DW; Zhou QT; Jin GZ
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):185-9. PubMed ID: 9772676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system dopamine receptors.
    Creese I
    Adv Biochem Psychopharmacol; 1980; 21():235-42. PubMed ID: 6103649
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of multiple receptors for dopamine.
    Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
    [No Abstract]   [Full Text] [Related]  

  • 18. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 19. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
    Clement-Cormier Y; Abel M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
    Seeman P
    Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.